Richard B. Slansky, Chief Financial Officer at GenMark Diagnostics, Inc. (GNMK), sold 660 shares at $11.72 ($8K) on 2013-11-06, disclosed to the SEC on 2013-11-08.
Scheduled sale ($8k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GNMK | SELL | 2014-05-12 | $21K | — | Filing → |
| GNMK | SELL | 2014-03-13 | $20K | — | Filing → |
| GNMK | SELL | 2014-02-07 | $10K | — | Filing → |